EGF Theramed Health (EVAHF) Stock Price, News & Analysis

Company Overview

EGF Theramed Health Corp. engages in the development of psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression, as well as natural health and wellness products. The company is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: $0.07 to $0.07
• 50-Day Range: $0.01 to $0.23
• 52-Week Range: $0.01 to $0.29
• Volume: 2,450 shs
• Average Volume: 2,364 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EVAHF Stock Analysis - Frequently Asked Questions

How have EVAHF shares performed this year?

EGF Theramed Health's stock was trading at $0.1220 at the start of the year. Since then, EVAHF stock has decreased by 44.3% and is now trading at $0.0680.
View the best growth stocks for 2024 here.

When did EGF Theramed Health's stock split?

EGF Theramed Health shares reverse split before market open on Monday, July 11th 2022. The 1-20 reverse split was announced on Monday, July 11th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 11th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of EGF Theramed Health?

Shares of EVAHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EVAHF
• CUSIP: N/A
• CIK: N/A
• Web: theramedhealthcorp.com
• Phone: (778) 331-4303
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A